{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:49:31Z","timestamp":1774486171774,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["ZIA EB000073"],"award-info":[{"award-number":["ZIA EB000073"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00259-017-3910-2","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T20:47:49Z","timestamp":1514494069000},"page":"585-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Preclinical evaluation of an 18F-trifluoroborate methionine derivative for glioma imaging"],"prefix":"10.1007","volume":"45","author":[{"given":"Xiangyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeva P.","family":"Munasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaojun","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9622-0870","authenticated-orcid":false,"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,29]]},"reference":[{"key":"3910_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00259-001-0690-4","volume":"29","author":"JK Chung","year":"2002","unstructured":"Chung JK, Kim YK, Kim SK, Lee YJ, Paek S, Yeo JS, et al. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2002;29:176\u201382.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3910_CR2","first-page":"1806","volume":"36","author":"P Lindholm","year":"1995","unstructured":"Lindholm P, Leskinen S, Nagren K, Lehikoinen P, Ruotsalainen U, Teras M, et al. Carbon-11-methionine PET imaging of malignant melanoma. J Nucl Med. 1995;36:1806\u201310.","journal-title":"J Nucl Med"},{"key":"3910_CR3","doi-asserted-by":"publisher","first-page":"W529","DOI":"10.1093\/nar\/gkq399","volume":"38","author":"H Ashkenazy","year":"2010","unstructured":"Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N. ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res. 2010;38:W529\u201333.","journal-title":"Nucleic Acids Res"},{"key":"3910_CR4","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/nar\/gkn072","volume":"36","author":"J Pei","year":"2008","unstructured":"Pei J, Kim BH, Grishin NV. PROMALS3D: a tool for multiple protein sequence and structure alignments. Nucleic Acids Res. 2008;36:2295\u2013300.","journal-title":"Nucleic Acids Res"},{"key":"3910_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.biopha.2013.05.003","volume":"67","author":"J Wang","year":"2013","unstructured":"Wang J, Chen X, Su L, Li P, Liu B, Zhu Z. LAT-1 functions as a promotor in gastric cancer associated with clinicopathologic features. Biomed Pharmacother. 2013;67:693\u20139.","journal-title":"Biomed Pharmacother"},{"key":"3910_CR6","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/cam4.272","volume":"3","author":"N Yanagisawa","year":"2014","unstructured":"Yanagisawa N, Hana K, Nakada N, Ichinoe M, Koizumi W, Endou H, et al. High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas. Cancer Med. 2014;3:1246\u201355.","journal-title":"Cancer Med"},{"key":"3910_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1349-7006.2011.02151.x","volume":"103","author":"M Furuya","year":"2012","unstructured":"Furuya M, Horiguchi J, Nakajima H, Kanai Y, Oyama T. Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis. Cancer Sci. 2012;103:382\u20139.","journal-title":"Cancer Sci"},{"key":"3910_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S1476-5586(04)80054-X","volume":"6","author":"J Lin","year":"2004","unstructured":"Lin J, Raoof DA, Thomas DG, Greenson JK, Giordano TJ, Robinson GS, et al. L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma. Neoplasia. 2004;6:74\u201384.","journal-title":"Neoplasia"},{"key":"3910_CR9","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1158\/0008-5472.CAN-08-2345","volume":"69","author":"A Detta","year":"2009","unstructured":"Detta A, Cruickshank GS. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Res. 2009;69:2126\u201332.","journal-title":"Cancer Res"},{"key":"3910_CR10","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1365-2559.2009.03300.x","volume":"54","author":"H Imai","year":"2009","unstructured":"Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, et al. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology. 2009;54:804\u201313.","journal-title":"Histopathology"},{"key":"3910_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/1471-2407-13-509","volume":"13","author":"H Betsunoh","year":"2013","unstructured":"Betsunoh H, Fukuda T, Anzai N, Nishihara D, Mizuno T, Yuki H, et al. Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma. BMC Cancer. 2013;13:509.","journal-title":"BMC Cancer"},{"key":"3910_CR12","first-page":"1393","volume":"39","author":"P Lindholm","year":"1998","unstructured":"Lindholm P, Leskinen S, Lapela M. Carbon-11-methionine uptake in squamous cell head and neck cancer. J Nucl Med. 1998;39:1393\u20137.","journal-title":"J Nucl Med"},{"key":"3910_CR13","first-page":"1886","volume":"34","author":"H Miyazawa","year":"1993","unstructured":"Miyazawa H, Arai T, Iio M, Hara T. PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters. J Nucl Med. 1993;34:1886\u201391.","journal-title":"J Nucl Med"},{"key":"3910_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12149-007-0035-x","volume":"21","author":"K Kanegae","year":"2007","unstructured":"Kanegae K, Nakano I, Kimura K, Kaji H, Kuge Y, Shiga T, et al. Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis. Ann Nucl Med. 2007;21:331\u20137.","journal-title":"Ann Nucl Med"},{"key":"3910_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1148\/radiol.2422051980","volume":"242","author":"A Dankerl","year":"2007","unstructured":"Dankerl A, Liebisch P, Glatting G, Friesen C, Blumstein NM, Kocot D, et al. Multiple myeloma: molecular imaging with 11C-Methionine PET\/CT--initial experience. Radiology. 2007;242:498\u2013508.","journal-title":"Radiology"},{"key":"3910_CR16","first-page":"173","volume":"56","author":"B Gulyas","year":"2012","unstructured":"Gulyas B, Halldin C. New PET radiopharmaceuticals beyond FDG for brain tumor imaging. Q J Nucl Med Mol Imaging. 2012;56:173\u201390.","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"3910_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00259-012-2295-5","volume":"40","author":"AW Glaudemans","year":"2013","unstructured":"Glaudemans AW, Enting RH, Heesters MA, Dierckx RA, van Rheenen RW, Walenkamp AM, et al. Value of 11C-methionine PET in imaging brain tumours and metastases. Eur J Nucl Med Mol Imaging. 2013;40:615\u201335.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3910_CR18","first-page":"847","volume":"36","author":"N Kawai","year":"2008","unstructured":"Kawai N, Kagawa M, Hatakeyama T, Tamiya T, Noshiyama Y, Yamamoto Y, et al. 11C-methionine positron emission tomography in brain tumor. No Shinkei Geka. 2008;36:847\u201359.","journal-title":"No Shinkei Geka"},{"key":"3910_CR19","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.2967\/jnumed.109.065904","volume":"50","author":"RT Ullrich","year":"2009","unstructured":"Ullrich RT, Kracht L, Brunn A, Herholz K, Frommolt P, Miletic H, et al. Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. J Nucl Med. 2009;50:1962\u20138.","journal-title":"J Nucl Med"},{"key":"3910_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2967\/jnumed.107.048082","volume":"49","author":"Y Terakawa","year":"2008","unstructured":"Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, et al. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med. 2008;49:694\u20139.","journal-title":"J Nucl Med"},{"key":"3910_CR21","first-page":"151","volume":"52","author":"R Laforest","year":"2008","unstructured":"Laforest R, Liu X. Image quality with non-standard nuclides in PET. Q J Nucl Med Mol Imaging. 2008;52:151\u20138.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"3910_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1500694","volume":"1","author":"Z Liu","year":"2015","unstructured":"Liu Z, Chen H, Chen K, Shao Y, Kiesewetter DO, Niu G, et al. Boramino acid as a marker for amino acid transporters. Sci Adv. 2015;1:e1500694.","journal-title":"Sci Adv"},{"key":"3910_CR23","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1248\/bpb.31.1096","volume":"31","author":"CS Kim","year":"2008","unstructured":"Kim CS, Cho SH, Chun HS, Lee SY, Endou H, Kanai Y, et al. BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells. Biol Pharm Bull. 2008;31:1096\u2013100.","journal-title":"Biol Pharm Bull"},{"key":"3910_CR24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3910_CR25","first-page":"1367","volume":"30","author":"HH Coenen","year":"1989","unstructured":"Coenen HH, Kling P, Stocklin G. Cerebral metabolism of L-[2-18F]fluorotyrosine, a new PET tracer of protein synthesis. J Nucl Med. 1989;30:1367\u201372.","journal-title":"J Nucl Med"},{"key":"3910_CR26","first-page":"663","volume":"39","author":"T Inoue","year":"1998","unstructured":"Inoue T, Tomiyoshi K, Higuichi T, Ahmed K, Sarwar M, Aoyagi K, et al. Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent. J Nucl Med. 1998;39:663\u20137.","journal-title":"J Nucl Med"},{"key":"3910_CR27","first-page":"331","volume":"40","author":"TM Shoup","year":"1999","unstructured":"Shoup TM, Olson J, Hoffman JM, Votaw J, Eshima D, Eshima L, et al. Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. J Nucl Med. 1999;40:331\u20138.","journal-title":"J Nucl Med"},{"key":"3910_CR28","first-page":"205","volume":"40","author":"HJ Wester","year":"1999","unstructured":"Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40:205\u201312.","journal-title":"J Nucl Med"},{"key":"3910_CR29","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2967\/jnumed.111.101279","volume":"53","author":"K Ploessl","year":"2012","unstructured":"Ploessl K, Wang L, Lieberman BP, Qu W, Kung HF. Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents. J Nucl Med. 2012;53:1616\u201324.","journal-title":"J Nucl Med"},{"key":"3910_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.nucmedbio.2013.09.011","volume":"41","author":"L Wang","year":"2014","unstructured":"Wang L, Lieberman BP, Ploessl K, Kung HF. Synthesis and evaluation of (1)(8)F labeled FET prodrugs for tumor imaging. Nucl Med Biol. 2014;41:58\u201367.","journal-title":"Nucl Med Biol"},{"key":"3910_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3945\/an.111.000661","volume":"2","author":"CH Halsted","year":"2011","unstructured":"Halsted CH, Medici V. Vitamin-dependent methionine metabolism and alcoholic liver disease. Adv Nutr. 2011;2:421\u20137.","journal-title":"Adv Nutr"}],"updated-by":[{"DOI":"10.1007\/s00259-026-07835-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000}}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-017-3910-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3910-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3910-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T23:40:09Z","timestamp":1774482009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-017-3910-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,29]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3910"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3910-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,29]]},"assertion":[{"value":"26 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The authors regret that the version of Figure 5 that appeared in the original published article is incorrect. The incorrect and correct version of Figure 5 are shown in the erratum article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00259-026-07835-0","URL":"https:\/\/doi.org\/10.1007\/s00259-026-07835-0","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}